Thursday, August 25, 2011 4:39:51 PM
FDA Approves Shire's Treatment For Swelling Disorder
11:14a ET August 25, 2011 (Dow Jones)
FDA Approves Shire's Treatment For Swelling Disorder
DOW JONES NEWSWIRES
Shire PLC's (SHPGY, SHP.LN) treatment for a rare swelling disorder was approved by the U.S. Food and Drug Administration.
The drug, Firazyr, is the third drug approved in the U.S. to treat attacks of a rare condition called hereditary angioedema, according to the FDA.
Firazyr is the first on-demand treatment for hereditary agiodema that patients can inject themselves when they feel an attack coming on, instead of seeking a health-care professional. This rare disorder is a potentially fatal condition that causes severe swelling in the hands and feet, gastrointestinal tract and upper airway.
The other FDA approved treatments are CSL Behring's Berinert to treat facial and abdominal attacks of the condition, and Dyax Corp.'s (DYAX) Kalbitor to treat acute attacks in patients ages 16 years and older.
-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM